🔎 Trials Near Me

Gara Jalqabaatti › Myeloproliferative Neoplasms › Massachusetts › Boston

Qorannoo klinikaalii Myeloproliferative Neoplasms Boston, MA keessatti

Qorannoo 14 Myeloproliferative Neoplasms f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Tufts Medical Center, Boston
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Tufts Medical Center, Boston
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04996875

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT03471260

Project: Every Child for Younger Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • Brigham and Women's Hospital, Boston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07020533

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Namoota walitti qabaa jiraSadarkaa 1
  • Mass General Brigham, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07249840

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 1
  • Boston Children's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT04024761

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06138587

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT06034002

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
  • DFCI/BWH Brigham and Women's Hospital, Boston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06059391

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

Namoota walitti qabaa jira
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Massachusetts General Hospital Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT05842603

Qorannoo Myeloproliferative Neoplasms magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.